Yaping L. Li

No. 157, Xi'wu Road
Xi'an, 710004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Add-on PD-1 inhibitor with Peg-IFNα therapy favors functional cure of chronic hepatitis B patients.

Add-on PD-1 inhibitor with Peg-IFNα therapy favors functional cure of chronic hepatitis B patients.

Journal: Journal of translational internal medicine

Published: February 23, 2026

Global burden of liver cancer from 1990 to 2021 and 20-year projections: findings from the global burden of disease study 2021.

Global burden of liver cancer from 1990 to 2021 and 20-year projections: findings from the global burden of disease study 2021.

Journal: International journal of surgery (London, England)

Published: November 13, 2025

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.

Journal: BMJ open

Published: September 21, 2025

Metabolomic and clinical feature analyses of plasma from influenza A patients.

Metabolomic and clinical feature analyses of plasma from influenza A patients.

Journal: Scientific reports

Published: May 07, 2025

Integrative scRNA-seq and transcriptomic analysis initially reveals monocyte/macrophage activation drives EV-A71-induced immune dysregulation and neural injury in severe HFMD.

Integrative scRNA-seq and transcriptomic analysis initially reveals monocyte/macrophage activation drives EV-A71-induced immune dysregulation and neural injury in severe HFMD.

Journal: Frontiers in immunology

Published: April 29, 2025

Retraction Note: Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.

Retraction Note: Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.

Journal: Functional & integrative genomics

Published: February 28, 2025

Plasma nontargeted metabolomics study of H1N1 and H3N2 influenza in children.

Plasma nontargeted metabolomics study of H1N1 and H3N2 influenza in children.

Journal: Frontiers in cellular and infection microbiology

Published: December 01, 2024

Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study.

Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study.

Journal: Journal of clinical and translational hepatology

Published: October 02, 2024

Peripheral Blood CD4+/CD8+ T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha.

Peripheral Blood CD4+/CD8+ T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha.

Journal: Journal of clinical and translational hepatology

Published: July 17, 2024

Clinical features of hand, foot and mouth disease caused by Coxsackievirus A6 in Xi'an, China, 2013-2019: A multicenter observational study.

Clinical features of hand, foot and mouth disease caused by Coxsackievirus A6 in Xi'an, China, 2013-2019: A multicenter observational study.

Journal: Acta tropica

Published: May 27, 2024

Global burden of liver cirrhosis 1990-2019 and 20 years forecast: results from the global burden of disease study 2019.

Global burden of liver cirrhosis 1990-2019 and 20 years forecast: results from the global burden of disease study 2019.

Journal: Annals of medicine

Published: May 10, 2024

Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression.

Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression.

Journal: Scientific reports

Published: August 29, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026